Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.

Literature DB >> 28161225

Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.

Sujan Ravi¹, Page Axley¹, DeAnn Jones², Sudha Kodali², Heather Simpson², Brendan M McGuire², Ashwani K Singal².

Abstract

Entities: Disease

Mesh：

Substances：
Antiviral Agents

Year: 2017 PMID： 28161225 DOI： 10.1053/j.gastro.2016.12.021

Source DB: PubMed Journal: Gastroenterology ISSN： 0016-5085 Impact factor: 22.682

Keyword Cloud
Cited

× No keyword cloud information.

39 in total

1. Safety concerns with the direct-acting antivirals for hepatitis C.

Authors: Alain Braillon
Journal: Aust Prescr Date: 2017-06-01

2. A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6.

Authors: Xiao Liu; Xiaoqiong Duan; Jacinta A Holmes; Wenting Li; Sae Hwan Lee; Zeng Tu; Chuanlong Zhu; Shadi Salloum; Anna Lidofsky; Esperance A Schaefer; Dachuan Cai; Shilin Li; Haoju Wang; Yongfu Huang; Yongju Zhao; Ming-Lung Yu; Zhiwen Xu; Limin Chen; Jian Hong; Wenyu Lin; Raymond T Chung
Journal: Hepatology Date: 2019-02-13 Impact factor: 17.425

3. Risk of hepatocellular carcinoma for patients treated with direct-acting antivirals: steps after hepatitis C virus eradication to achieve elimination.

Authors: Mei-Hsuan Lee
Journal: Transl Gastroenterol Hepatol Date: 2018-03-05

4. Risk of De Novo Hepatocellular Carcinoma Following Use of Direct Acting Antiviral Medications for Treatment of Chronic Hepatitis C.

Authors: Samuel O Antwi; Holly K Van Houten; Lindsey R Sangaralingham; Tushar Patel
Journal: Cancer Prev Res (Phila) Date: 2019-08-26

Review 5. Interaction Between Hepatocellular Carcinoma and Hepatitis C Eradication With Direct-acting Antiviral Therapy.

Authors: Venkata Rajesh Konjeti; Binu V John
Journal: Curr Treat Options Gastroenterol Date: 2018-06

Review 6. AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.

Authors: Amit G Singal; Joseph K Lim; Fasiha Kanwal
Journal: Gastroenterology Date: 2019-03-13 Impact factor: 22.682

7. Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience.

Authors: Bülent Değertekin; Mehmet Demir; Ulus S Akarca; Haluk Tarık Kani; Enver Üçbilek; Emre Yıldırım; Fatih Güzelbulut; Ayhan Balkan; Sezgin Vatansever; Nilay Danış; Melek Demircan; Aliye Soylu; Serkan Yaras; Aysun Kartal; Ayşe Kefeli; Feyza Gündüz; Kendal Yalçın; Elife Erarslan; Murat Aladağ; Murat Harputluoğlu; Ayşegül Özakyol; Tuncer Temel; Mesut Akarsu; Hale Sümer; Mete Akın; Bülent Albayrak; İlker Sen; Hüseyin Alkım; Ahmet Uyanıkoğlu; Kader Irak; Sinem Öztaşkın; Çağrı Burak Uğurlu; Şevkican Güneş; Selim Gürel; Kenan Nuriyev; İsmail İnci; Sabite Kaçar; Dinç Dinçer; Levent Doğanay; Hüseyin Savaş Göktürk; Ali Mert; Arif Mansur Coşar; Hakan Dursun; Roni Atalay; Sabiye Akbulut; Yasemin Balkan; Hayrettin Koklu; Halis Şimşek; Osman Özdoğan; Mehmet Çoban
Journal: Turk J Gastroenterol Date: 2020-12 Impact factor: 1.852